Proventil and Braftovi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Proventil (albuterol) and Braftovi (encorafenib). Common drug interactions include dysuria among females and infection among males.

The phase IV clinical study analyzes what interactions people have when they take Proventil and Braftovi. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Proventil?

Proventil has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 16,110 Proventil users. Check the latest studies of Proventil.

What is Braftovi?

Braftovi has active ingredients of encorafenib. eHealthMe is studying from 7,609 Braftovi users. Check the latest studies of Braftovi.



On Jul, 08, 2026

12 people who take Proventil and Braftovi together, and have interactions are studied.

Proventil and Braftovi drug interactions.

What are the common drug interactions of Proventil and Braftovi, by gender? *:

female:

  1. Dysuria (painful or difficult urination)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Pneumonia
  4. Urinary tract infection

male:

  1. Infection
  2. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)

What are the common drug interactions of Proventil and Braftovi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Dysuria (painful or difficult urination)
  2. Infection
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  5. Pneumonia
  6. Urinary tract infection

What are the existing conditions these people have? *

  1. Malignant Melanoma (skin cancer rises from melancytes): 5 people, 41.67%
  2. Colon Cancer: 3 people, 25.00%
  3. Metastases To Lung (cancer spreads to lung): 2 people, 16.67%
  4. Thyroid Cancer: 1 person, 8.33%
  5. Metastasis (spreadable cancer to other organ from origin): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Proventil and Braftovi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Proventil and Braftovi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Proventil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Braftovi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proventil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Braftovi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on albuterol and encorafenib (the active ingredients of Proventil and Braftovi, respectively), and Proventil and Braftovi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: